- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
MFG Wealth Management Inc. Acquires 20,156 Shares of Bristol Myers Squibb
The investment firm added a new stake in the biopharmaceutical company's stock in Q4 2025.
Mar. 21, 2026 at 10:22am
Got story updates? Submit your updates here. ›
MFG Wealth Management Inc. acquired a new stake of 20,156 shares in Bristol Myers Squibb Company (NYSE:BMY) during the fourth quarter of 2025, according to the firm's latest 13F filing with the SEC. The shares were valued at approximately $1,087,000.
Why it matters
This investment by MFG Wealth Management Inc. reflects institutional interest and confidence in Bristol Myers Squibb, a major biopharmaceutical company with a diverse portfolio of drugs and a strong pipeline. The acquisition adds to the growing institutional ownership of BMY stock.
The details
MFG Wealth Management Inc. purchased the 20,156 shares of Bristol Myers Squibb in the fourth quarter. The investment firm now holds a new stake in the biopharmaceutical company's stock, valued at around $1.087 million. Other institutional investors and hedge funds also made changes to their BMY holdings during the quarter, with some adding to their positions and others reducing their stakes.
- MFG Wealth Management Inc. acquired the 20,156 shares of Bristol Myers Squibb in the fourth quarter of 2025.
The players
MFG Wealth Management Inc.
An investment firm that acquired a new stake in shares of Bristol Myers Squibb Company in the fourth quarter of 2025.
Bristol Myers Squibb Company
A global biopharmaceutical company focused on discovering, developing, and delivering medicines for serious diseases.
The takeaway
This investment by MFG Wealth Management Inc. demonstrates ongoing institutional interest in Bristol Myers Squibb, a leading biopharmaceutical company with a diverse product portfolio and robust pipeline. The acquisition adds to the growing institutional ownership of BMY stock, which could signal confidence in the company's long-term growth prospects.
